Literature DB >> 18422867

Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia.

Jeng-Sen Tseng1, Ming-Cheng Chan, Jeng-Yuan Hsu, Benjamin Ing-Tiau Kuo, Chieh-Liang Wu.   

Abstract

BACKGROUND AND
OBJECTIVE: ARDS is life-threatening acute respiratory failure, and pneumonia is one of the most common causes of direct ARDS. Procalcitonin (PCT) has been evaluated for its utility in determining the aetiology of community-acquired pneumonia (CAP), choice of antibiotics and prediction of outcome. This study evaluated the role of PCT in predicting the outcome of patients with ARDS caused by severe CAP.
METHODS: This was a prospective observational study conducted from September 2002 to December 2003. The plasma PCT was analysed at baseline, 24 and 72 h after enrolment and measured by ELISA.
RESULTS: Of the 22 patients with ARDS caused by CAP and enrolled in the study, 17 (77.3%) were alive 14 days after admission and five (22.7%) had died. The survivors had lower APACHE II scores (22.2 +/- 4.6 vs 30.6 +/- 9.6, P = 0.031), pneumonia severity index (141.9 +/- 2.2 vs 195.6 +/- 23.8, P = 0.005) and lower plasma PCT at baseline (9.83 +/- 3.54 vs 106.70 +/- 67.86, P = 0.004), at 24 h (10.51 +/- 5.39 vs 81.32 +/- 57.68, P = 0.014) and at 72 h (2.03 +/- 0.76 vs 19.57 +/- 6.67, P = 0.005).
CONCLUSION: PCT analysed within 72 h of the onset of ARDS predicted mortality of patients with ARDS caused by severe CAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422867     DOI: 10.1111/j.1440-1843.2008.01293.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  10 in total

1.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 2.  Biomarkers in acute lung injury--marking forward progress.

Authors:  Nicolas Barnett; Lorraine B Ware
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

3.  Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.

Authors:  Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang
Journal:  Respirology       Date:  2014-01-26       Impact factor: 6.424

4.  Early assessment of pulmonary inflammation by 19F MRI in vivo.

Authors:  Bernd Ebner; Patrick Behm; Christoph Jacoby; Sandra Burghoff; Brent A French; Jürgen Schrader; Ulrich Flögel
Journal:  Circ Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 7.792

Review 5.  The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review.

Authors:  Leon Peto; Behzad Nadjm; Peter Horby; Ta Thi Dieu Ngan; Rogier van Doorn; Nguyen Van Kinh; Heiman F L Wertheim
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-04-29       Impact factor: 2.184

6.  Aetiology, outcomes & predictors of mortality in acute respiratory distress syndrome from a tertiary care centre in north India.

Authors:  Surendra K Sharma; Anunay Gupta; Ashutosh Biswas; Abhishek Sharma; Atul Malhotra; K T Prasad; Sreenivas Vishnubhatla; Sajal Ajmani; Hridesh Mishra; Manish Soneja; Shobha Broor
Journal:  Indian J Med Res       Date:  2016-06       Impact factor: 2.375

7.  Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital.

Authors:  Takanori Akagi; Nobuhiko Nagata; Hiroyuki Miyazaki; Taishi Harada; Satoshi Takeda; Yuji Yoshida; Kenji Wada; Masaki Fujita; Kentaro Watanabe
Journal:  BMC Geriatr       Date:  2019-01-07       Impact factor: 3.921

8.  Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: A network meta-analysis.

Authors:  Jiawen Li; Kaiyu Zhou; Hongyu Duan; Peng Yue; Xiaolan Zheng; Lei Liu; Hongyu Liao; Jinlin Wu; Jinhui Li; Yimin Hua; Yifei Li
Journal:  PLoS One       Date:  2022-02-23       Impact factor: 3.240

Review 9.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

Review 10.  Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis.

Authors:  Dan Liu; Long-Xiang Su; Wei Guan; Kun Xiao; Li-Xin Xie
Journal:  Respirology       Date:  2015-12-10       Impact factor: 6.424

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.